Saturday 7 November 2026
Export GCTK’s income statement to Excel — free account
GlucoTrack, Inc.
GCTK Healthcare Medical Devices
- EPS
- +92.1%
- Free cash flow
- +3.42%
- Total debt
- +777.8%
Quarter to June 2026, against a year earlier
0.30
0.08
−21.05%
Follow GCTK
Alert me
GlucoTrack, Inc. (GCTK) P/E ratio
GlucoTrack, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
| FY2015 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Dec 2019 | 0.0× | — |
| Sep 2019 | 0.0× | — |
| Jun 2019 | 0.0× | — |
| Mar 2019 | 0.0× | — |
| 13 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | n/m |
| DHAI DIH Holding US, Inc. compare | n/m |
| BJDX Bluejay Diagnostics, Inc. compare | n/m |
| NXL Nexalin Technology, Inc. compare | n/m |
| CODX Co-Diagnostics, Inc. compare | n/m |
| ADGM Adagio Medical Holdings, Inc. compare | n/m |
| IVF INVO Fertility, Inc compare | n/m |
| GCTK GlucoTrack, Inc. | n/m |
| ICCM IceCure Medical Ltd. compare | n/m |
| Medical Devices industry median | 24.9× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)